Sorry, there was no activity found. Please try a different filter.
Public Groupactive 2 weeks ago
Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical businesses, which includes the makers of Xarelto, have a duty to ensure that their drugs are reasonably safe for use – and failure to perform so might be grounds for compensation. Our lawyers are functioning tough to have those hurt by the drug the compensation they may be entitled to.
Although bleeding is a typical complication connected with anticoagulants, it has been alleged that Xarelto is a lot more harmful than traditional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This signifies that, within the event of an emergency, patients could be at danger for irreversible bleeding troubles, including life-threatening internal and gastrointestinal hemorrhaging.
If you or perhaps a loved a single suffered a significant bleeding occasion after taking Xarelto, you might have legal recourse. For a lot more data, get in touch with us right now to possess your case reviewed, totally free of charge.
xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future healthcare bills, lost wages, pain and suffering and, in cases of death, funeral expenses. Furthermore, they may be seeking punitive damages, that are normally awarded to punish the defendant and deter other names for xarelto firms from acting similarly.
Why Are Lawsuits Becoming Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs within the lawsuits allege significant and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.
Visit this page for more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.